Project Description

Bonalive® Orthopedics granules

A synthetic, osteoconductive and bioactive material. Manufactured by Bonalive Biomaterials Ltd in Finland from a unique S53P4 bioactive glass, characterized by its ability to firmly attach to living tissue. Indicated for bony voids or gaps that are not intrinsic to the stability of the bony structure.

  • Produces natural hydroxyapatite, which resembles the mineral phase of natural bone
  • Bonds chemically with surrounding bone

  • Promotes new bone formation in the implanted area

Bonalive Orthopedics granules Surgical Technique

Bonalive Orthopedics granules Surgical Technique Cover

Animation

For more information visit www.bonalive.com

  1. Molecular basis for action of bioactive glasses as bone graft substitute.
    Välimäki V.-V, Aro H. Scand J Surg. 2006;95(2):95-102.
  2. Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in
    augmentation of bone defect healing.
    Virolainen P, Heikkilä J, Yli-Urpo A, Vuorio E, Aro H. J Biomed Mater Res Part A. 1997;35(1):9-17.
Bonalive Orthopedics Granules

Bonalive® Orthopedics granules

A synthetic, osteoconductive and bioactive material. Manufactured by Bonalive Biomaterials Ltd in Finland from a unique S53P4 bioactive glass, characterized by its ability to firmly attach to living tissue. Indicated for bony voids or gaps that are not intrinsic to the stability of the bony structure.

  • Produces natural hydroxyapatite, which resembles the mineral phase of natural bone
  • Bonds chemically with surrounding bone

  • Promotes new bone formation in the implanted area

Bonalive Orthopedics granules Surgical Technique

Bonalive Orthopedics granules Surgical Technique Cover

Animation

For more information visit www.bonalive.com

  1. Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in
    augmentation of bone defect healing.
    Virolainen P, Heikkilä J, Yli-Urpo A, Vuorio E, Aro H. J Biomed Mater Res Part A. 1997;35(1):9-17.
  2. Molecular basis for action of bioactive glasses as bone graft substitute.
    Välimäki V.-V, Aro H. Scand J Surg. 2006;95(2):95-102.